StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · HELP·Healthcare

Cybin Inc. Common Stock Stock Analysis & AI Score

Cybin Inc. Common Stock (HELP) has an ST Score of 62.3 (B), driven by its Financial Strength (A+) and held back by its Profitability (C-). Analysts rate it Buy with a $22.00 price target (+74.7% upside).

Market Closed
$12.59
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
62
ST Score
62.3/100B

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

HELP
62.3out of 100
Grade B

Cybin Inc. Common Stock (HELP) has an ST Score of 62.3 (B), driven by its Financial Strength (A+) and held back by its Profitability (C-). Analysts rate it Buy with a $22.00 price target (+74.7% upside).

Strongest
Financial StrengthA+
Weakest
ProfitabilityC-
All factor grades
  • Financial StrengthA+
  • ValuationA
  • MomentumA-
  • ForecastB+
  • GrowthC
  • ProfitabilityC-
  • Piotroski3/9
Score methodology
Press Releases

Contact

HELP stock: frequently asked questions

What is HELP's ST Score?

Cybin Inc. Common Stock (HELP) has an ST Score of 62.3 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is HELP a buy, hold, or sell?

Analysts rate HELP a Buy, with a price target of $22.00 (+74.7% vs the current price). Our ST Score grades it B (62.3/100). The ST Score is a data-driven signal, not a recommendation.

What are HELP's factor grades?

Valuation A, Profitability C-, Financial Strength A+, Momentum A-, Growth C, Forecast B+.

What is HELP's valuation grade?

Cybin Inc. Common Stock (HELP) earns a valuation grade of A, measured against Medical - Pharmaceuticals peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is HELP's growth grade?

Cybin Inc. Common Stock (HELP) earns a growth grade of C, measured against Medical - Pharmaceuticals peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is HELP's profitability grade?

Cybin Inc. Common Stock (HELP) earns a profitability grade of C-, measured against Medical - Pharmaceuticals peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is HELP's financial strength grade?

Cybin Inc. Common Stock (HELP) earns a financial strength grade of A+, measured against Medical - Pharmaceuticals peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for HELP?

The average analyst price target for Cybin Inc. Common Stock (HELP) is $22.00 from 4 analysts, which is +74.7% versus the recent price of $12.59.

What is HELP's Piotroski score?

Cybin Inc. Common Stock (HELP) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.